622 related articles for article (PubMed ID: 27748532)
21. Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.
Li X; Ominsky MS; Warmington KS; Niu QT; Asuncion FJ; Barrero M; Dwyer D; Grisanti M; Stolina M; Kostenuik PJ; Simonet WS; Paszty C; Ke HZ
Endocrinology; 2011 Sep; 152(9):3312-22. PubMed ID: 21733832
[TBL] [Abstract][Full Text] [Related]
22. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
[TBL] [Abstract][Full Text] [Related]
23. Formononetin reverses established osteopenia in adult ovariectomized rats.
Tyagi AM; Srivastava K; Singh AK; Kumar A; Changkija B; Pandey R; Lahiri S; Nagar GK; Yadav DK; Maurya R; Trivedi R; Singh D
Menopause; 2012 Aug; 19(8):856-63. PubMed ID: 22781783
[TBL] [Abstract][Full Text] [Related]
24. Bone anabolic effects of separate and combined therapy with growth hormone and parathyroid hormone on femoral neck in aged ovariectomized osteopenic rats.
Wang L; Orhii PB; Banu J; Kalu DN
Mech Ageing Dev; 2001 Jan; 122(1):89-104. PubMed ID: 11163626
[TBL] [Abstract][Full Text] [Related]
25. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats.
Peng S; Zhang G; Zhang BT; Guo B; He Y; Bakker AJ; Pan X; Zhen W; Hung L; Qin L; Leung WN
Bone; 2013 Jul; 55(1):230-40. PubMed ID: 23486180
[TBL] [Abstract][Full Text] [Related]
26. Odanacatib, effects of 16-month treatment and discontinuation of therapy on bone mass, turnover and strength in the ovariectomized rabbit model of osteopenia.
Duong LT; Crawford R; Scott K; Winkelmann CT; Wu G; Szczerba P; Gentile MA
Bone; 2016 Dec; 93():86-96. PubMed ID: 27639811
[TBL] [Abstract][Full Text] [Related]
27. Effects of prostaglandin E2 and F2 alpha on the skeleton of osteopenic ovariectomized rats.
Ma YF; Li XJ; Jee WS; McOsker J; Liang XG; Setterberg R; Chow SY
Bone; 1995 Dec; 17(6):549-54. PubMed ID: 8835309
[TBL] [Abstract][Full Text] [Related]
28. Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats.
Ma YL; Bryant HU; Zeng Q; Schmidt A; Jee WS; Sato M
J Bone Miner Metab; 2005; 23 Suppl():62-8. PubMed ID: 15984416
[TBL] [Abstract][Full Text] [Related]
29. Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibody.
Li X; Niu QT; Warmington KS; Asuncion FJ; Dwyer D; Grisanti M; Han CY; Stolina M; Eschenberg MJ; Kostenuik PJ; Simonet WS; Ominsky MS; Ke HZ
Endocrinology; 2014 Dec; 155(12):4785-97. PubMed ID: 25259718
[TBL] [Abstract][Full Text] [Related]
30. A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats.
Iwaniec UT; Moore K; Rivera MF; Myers SE; Vanegas SM; Wronski TJ
Osteoporos Int; 2007 Mar; 18(3):351-62. PubMed ID: 17120182
[TBL] [Abstract][Full Text] [Related]
31. Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys.
Yamada H; Ochi Y; Mori H; Nishikawa S; Hashimoto Y; Nakanishi Y; Tanaka M; Bruce M; Deacon S; Kawabata K
Bone; 2016 May; 86():43-52. PubMed ID: 26921823
[TBL] [Abstract][Full Text] [Related]
32. Time course of disassociation of bone formation signals with bone mass and bone strength in sclerostin antibody treated ovariectomized rats.
Ma YL; Hamang M; Lucchesi J; Bivi N; Zeng Q; Adrian MD; Raines SE; Li J; Kuhstoss SA; Obungu V; Bryant HU; Krishnan V
Bone; 2017 Apr; 97():20-28. PubMed ID: 27939957
[TBL] [Abstract][Full Text] [Related]
33. Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis.
Li X; Ominsky MS; Villasenor KS; Niu QT; Asuncion FJ; Xia X; Grisanti M; Wronski TJ; Simonet WS; Ke HZ
Endocrinology; 2018 Jan; 159(1):260-271. PubMed ID: 29069393
[TBL] [Abstract][Full Text] [Related]
34. Prostaglandin E2 increased rat cortical bone mass when administered immediately following ovariectomy.
Ke HZ; Jee WS; Zeng QQ; Li M; Lin BY
Bone Miner; 1993 Jun; 21(3):189-201. PubMed ID: 8400919
[TBL] [Abstract][Full Text] [Related]
35. Long-term treatment with eldecalcitol (1α, 25-dihydroxy-2β- (3-hydroxypropyloxy) vitamin D3) suppresses bone turnover and leads to prevention of bone loss and bone fragility in ovariectomized rats.
Takeda S; Smith SY; Tamura T; Saito H; Takahashi F; Samadfam R; Haile S; Doyle N; Endo K
Calcif Tissue Int; 2015 Jan; 96(1):45-55. PubMed ID: 25467010
[TBL] [Abstract][Full Text] [Related]
36. Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice.
Arlt H; Mullarkey T; Hu D; Baron R; Ominsky MS; Mitlak B; Lanske B; Besschetnova T
Bone Rep; 2020 Dec; 13():100291. PubMed ID: 32637467
[TBL] [Abstract][Full Text] [Related]
37. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
[TBL] [Abstract][Full Text] [Related]
38. Abaloparatide, the second generation osteoanabolic drug: Molecular mechanisms underlying its advantages over the first-in-class teriparatide.
Bhattacharyya S; Pal S; Chattopadhyay N
Biochem Pharmacol; 2019 Aug; 166():185-191. PubMed ID: 31136739
[TBL] [Abstract][Full Text] [Related]
39. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
40. Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women With Osteoporosis.
Dempster DW; Zhou H; Rao SD; Recknor C; Miller PD; Leder BZ; Annett M; Ominsky MS; Mitlak BH
J Bone Miner Res; 2021 Apr; 36(4):644-653. PubMed ID: 33434314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
